Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis

Abstract Background Comorbid autoimmune disorders, including rheumatoid arthritis (RA), are common in people with multiple sclerosis (MS). Both conditions share pathogenic similarities, enabling potential overlap in treatments. While numerous disease-modifying therapies (DMT) are approved for MS and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Grote-Levi, Kurt-Wolfram Sühs, Luisa Klotz, Steffen Pfeuffer, Refik Pul, Christoph Kleinschnitz, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-07-01
Serie:	Neurological Research and Practice
Soggetti:	Multiple sclerosis Rheumatoid arthritis Disease-modifying therapy Autoimmune disorders Treatment Beneficial and adverse effects
Accesso online:	https://doi.org/10.1186/s42466-025-00414-y
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!